Cytek BiosciencesCTKB
那斯達克 · USD
4.24
+0.05
(+1.19%)
收盤 06/02 03:59 (UTC+8)
06/02 03:59 (UTC+8)
Cytek BiosciencesCTKB
4.24
+0.05
(+1.19%)
財務數據
損益表
- 0.58
- 0.45
- 0.47
- 0.52
- 0.57
- 0.41
- 0.46
- 0.52
- 0.62
- 0.44
- 21.32
- -22.96
- 3.92
- 10.47
- 11.60
- -27.87
- 10.00
- 14.67
- 18.83
- -28.98
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 44,135 | 62,141 | 52,293 | 45,602 | 41,457 | 57,476 | 51,500 | 46,617 | 44,860 | 58,233 |
營業成本 | 22,881 | 29,256 | 24,742 | 21,735 | 21,300 | 23,824 | 22,495 | 21,181 | 21,847 | 25,185 |
營業毛利 | 21,254 | 32,885 | 27,551 | 23,867 | 20,157 | 33,652 | 29,005 | 25,436 | 23,013 | 33,048 |
營業費用 | 39,717 | 38,479 | 36,743 | 34,490 | - | - | - | - | - | 33,185 |
研發費用 | 9,604 | 8,962 | 8,956 | 8,825 | 9,725 | 9,723 | 9,883 | 10,000 | 9,796 | 10,869 |
推銷及管理費用 | 30,113 | 29,517 | 27,787 | 25,665 | 25,407 | 20,943 | 23,371 | 23,962 | 23,951 | 22,316 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -18,463 | -5,594 | -9,192 | -10,623 | -14,975 | 2,986 | -4,249 | -8,526 | -10,734 | -137 |
其他收入及費用 | 1,352 | 838 | 1,917 | 4,262 | 4,000 | 1,404 | 4,524 | 1,474 | 2,182 | 4,642 |
利息費用 | 262 | -1,199 | 494 | 414 | 291 | -694 | 119 | 134 | 441 | 394 |
稅前純益 | -17,373 | -4,031 | -7,769 | -6,775 | -11,266 | 10,323 | 156 | -7,186 | -8,993 | 4,111 |
所得稅 | 1,493 | 40,045 | -2,291 | -1,192 | 136 | 680 | -784 | 3,248 | -2,824 | -1,392 |
稅後純益 | -18,866 | -44,076 | -5,478 | -5,583 | -11,402 | 9,643 | 940 | -10,434 | -6,169 | 5,503 |
基本每股稅後盈餘(元) | -0.15 | -0.34 | -0.04 | -0.04 | -0.09 | 0.07 | 0.01 | -0.08 | -0.05 | - |
稀釋每股稅後盈餘(元) | -0.15 | -0.34 | -0.05 | -0.04 | -0.09 | 0.07 | 0.01 | -0.08 | -0.05 | 0.04 |
基本平均股數(千股) | 128704.00 | 128166.00 | 127547.00 | 126934.00 | 128339.00 | 129082.00 | 131003.00 | 131440.00 | 130920.00 | - |
稀釋平均股數(千股) | 128704.00 | 128166.00 | 127547.00 | 126934.00 | 128339.00 | 127300.00 | 132785.00 | 131440.00 | 130920.00 | - |
還原基本每股稅後盈餘(元) | -0.15 | -0.34 | -0.04 | -0.04 | -0.09 | 0.07 | 0.01 | -0.08 | -0.05 | - |
還原稀釋每股稅後盈餘(元) | -0.15 | -0.34 | -0.05 | -0.04 | -0.09 | 0.07 | 0.01 | -0.08 | -0.05 | 0.04 |
還原基本平均股數(千股) | 128,704 | 128,166 | 127,547 | 126,934 | 128,339 | 129,082 | 131,003 | 131,440 | 130,920 | - |
還原稀釋平均股數(千股) | 128,704 | 128,166 | 127,547 | 126,934 | 128,339 | 127,300 | 132,785 | 131,440 | 130,920 | - |
EBITDA(千元) | -14,345 | -2,948 | -4,074 | -3,229 | -7,943 | 4,666 | 3,149 | -4,426 | -5,791 | 7,196 |